Three defence mechanisms are responsible for the sterility of the normal tracheobronchial tree: the mucociliary escalator, which continuously traps inhaled micro-organisms; phagocytes; and the bronchial immune system. In the mucociliary system, the respiratory mucus which covers the respiratory mucosa is moved towards the pharnyx as a result of the beating of the cilia covering the airways epithelium, and is swallowed with the trapped bacteria.
Mucins are a major macromolecular component of respiratory mucus. They represent a large population of high molecular mass, polydisperse glycoproteins appearing as filaments by electron microscopy [ 1, 2] . They are synthesized in goblet cells of the airway surface and in mucous cells of the submucosal glands. They are important in mucus physical organization, and for its rheological properties, which are responsible for the efficiency of the mucociliary escalator. They are also able to interact with various micro-organisms, allowing their elimination from the respiratory tree.
T h e considerable diversity of mucins results from a dual mechanism, a variety of post-translational modifications (glycosylation and sulphation), in addition to the synthesis of various mucin polypeptides or apomucins. Respiratory apomucins (approx. 100-500 kDa) are a family of molecules encoded by different mucin genes, of which at least five genes, MUC2, MUC4, MUCSAC, MUCSB and MUC8, have been identified [3, 4] .
Mucin carbohydrate diversity
T h e average carbohydrate content of airway mucins is 80% by weight and, in a mucin molecule, the apomucin may be covered by several hundreds of carbohydrate chains linked by 0-glycosidic linkages. In such linkages, an Nacetylgalactosamine (GalNAc) residue at the reducing end of the carbohydrate chain is attached to a threonine (or serine) residue of the apomucin. The 0-glycan may contain from one (the GalNAc residue linked to the peptide) to about 20 sugars. Mucins may also contain a few N-gl ycans.
T h e first 0-glycosylation reactions (initiation) attach the first sugars (the core). They involve different glycosyltransferases: GalNActransferases, which attach the first GalNAc, and then galactosyl-and/or N-acetylglucosaminyltransferases, which attach galactose (Gal) and/or N-acetylglucosamine (GlcNAc) . Thus, different cores may be generated [5] , for example:
In addition to classical cores 1, 2, 3 and 4, human airway mucins may contain small amounts of core 8, Gal(a1-3)GalNAcal-0- [6] . Once the core is synthesized, elongation reactions involving galactosyl-and N-acetylglucosaminyltransferases create the backbone of the chains. As in other mucins, the backbone of respiratory mucins contains only two sugars, galactose and N-acetylglucosamine, arranged in two different types of disaccharide subunits, type 1 [Gal(P1-3)GlcNac] and type 2 [Gal(Pl-4)GlcNacI [5] . These chain backbones may be linear or branched and may represent antigenic determinants (I, i).
The chain termination occurs when peripheral sugars (fucose, N-acetylneuraminic acid, N-acetylgalactosamine or galactose), all in a-anomeric configuration, are added onto the different backbones or when sulphate is added. These reactions are the result of a series of transferases.
Fucosyltransferases ( Carbohydrate chains containing 'internal' H determinants may also be encountered in human airway mucin [ 71 :
Mucins from non-secretor individuals (se) contain no A, B or H determinants and only have Lewis a and X activities. Different sialyltransferases may attach Nacetylneuraminic acid (NeuAc) to the GalNAc residue of the core (in position 6), or on the terminal galactose residues of the chain backbone (in positions 3 or 6); the number of chains from human airway mucin having a terminal carbohydrate NeuAc(a2-3)Gal-is much larger than the number of chains having a terminal carbohydrate NeuAc(a2-6)Gal-[8,9], implying that the goblet cells or the submucosal glands express predominantly a2-3Gal sialyltransferase activities, as compared with the a2-6Gal sialyltransferase. The a2-3 sialyltransferase, in combination with the Lewis enzyme, may generate the sialyl-X determinant known as a receptor for selectins (reviewed in [lo] ).
Sulphate groups may also be added by at least two different sulphotransferases adding sulphate groups either on the C3 of a terminal galactose or on the C6 of internal GlcNAc residues [ll]:
In many carbohydrate chains from human respiratory mucins, especially when they are branched, the different possible terminal substitutions (fucosylation, sialylation and sulphation) may coexist, thus the existence of pure sialo-or sulphomucins is questionable.
The carbohydrate chains of human respiratory mucins may be extremely diverse. More than 88 different chains have been observed in the mucins of one patient suffering from bronchiectasis [12] , and the mucins secreted by a single individual probably contain several hundreds of different carbohydrate chains.
As with other mucins, there is no information concerning any of the apomucins that are synthesized by the respiratory mucosa and a specific glycosylation pattern.
From a functional point of view, the reasons for the remarkable diversity of 0-glycans are puzzling. Such a mosaic of carbohydrate determinants may be very useful as targets to trap inhaled micro-organisms, thus protecting the underlying mucosa. Carbohydrate receptors for bacteria have also been identified using glycolipids or neoglycolipids that can be separated by thin-layer chromatography, followed by overlay with radiolabelled bacteria and autoradiography [ 191. Moreover, several carbohydrate determinants that are receptors for different micro-organisms such as Streptococcus pneumoniae, Mycoplasma pneumoniae and influenza virus (reviewed in [S]) are expressed on human respiratory mucins.
Microbial adhesions and mucin carbohydrate diversity
The entry of influenza viruses into respiratory cells is an interesting example of interactions. The binding of these viruses is mediated by viral haemagglutinins, which recognize cell surfaces containing terminal sialic acid residues. The haemagglutinins from different strains may differ in their ability to recognize various sialic acid-containing receptors [20] . Haemagglutinins from human strains of influenza A viruses preferentially recognize receptors with the terminal NeuAc (a2-6)Gal sequence, whereas haemagglutinins from avian strains preferentially recognize receptors with the terminal NeuAc(a2-3)Gal sequence [21, 22] . These two types of receptors are distributed differently in the tracheal epithelial cells, the NeuAc(a2-6)Gal sequence being primarily expressed on ciliated cells and the NeuAc(a2-3)Gal structure being mainly expressed in the goblet cells [23] as well as in their secreted products, the respiratory mucins [8,9]. In fact, human bronchial mucins are potent binding inhibitors for strains of the avian type recognizing the NeuAc (a2-3)Gal sequence, but not for viral strains of the human type recognizing the NeuAc(a2-6)Gal sequence [23] . Therefore the predominance of the NeuAc(a2-6)Gal sequence on ciliated cells and of the NeuAc(a2-3)Gal sequence on human respiratory mucins may combine to select for the receptor specificity of human influenza A virus strains 838 ~3 1 .
Lung infection in cystic fibrosis and airway mucins
Cystic fibrosis (CF) is a genetic disease that affects epithelia and exocrine glands. In its most typical form, the severity of the disease is due to a chronic lung infection and mucus hypersecretion, as in chronic bronchitis. Unlike chronic bronchitis, CF is characerized by a very specific bacterial colonization of airway mucus. Lung infection is characterized by the predominance of Staphylococcus aureus in early life and, rapidly thereafter, of Pseudomonas aeruginosa. The infection is almost impossible to eradicate and is rsponsible for most of the morbidity and mortality of the disease.
Cystic fibrosis is due to mutations of a gene localized on chromosome 7 encoding for CFTR (cystic fibrosis transmembrane regulator) a chloride channel of low conductance activatable by protein kinase A (for recent reviews, see [24, 25] ). CFTR mutations, such as the AF508 mutation, are responsible for water and electrolyte abnormalities of the respiratory mucosa, increased osmolarity [26] of the periciliary fluid and dehydration of the mucus layer [27] , which may impair the mucociliary system and lead to mucus stagnation.
The major problem in understanding the pathophysiology of CF is to relate these abnormalities to the specificity of the lung infection, especially by Pseudomonas aeruginosa.
In addition to water and electrolyte abnormalities, the CFTR defect, especially the AF508 mutation, which blocks the nascent CFTR in the endoplasmic reticulum [28] , may modify other cell functions, such as endocytosis [29] , and alter the acidification of the trans-GolgVtrans-Golgi network, leading to modifications in the sulphation and glycosylation processes [30-321. Increased sulphation of CF respiratory mucins [33-351 and of glycoconjugates secreted by CF respiratory epithelial cells in culture [36, 37] has been reported. Lower sialylation has been described for proteins secreted by CF respiratory cell lines [30] . An increased expression of asialo-GM1 has also been observed at the surface membrane of CF cells [38] .
Pseudomonas aeruginosa may adhere to CF airway cells in culture [38] . This interaction involves pilin and a cell receptor that is asialoGMl [39, 40] . However, in the CF lung, most of the bacteria are found in the mucus, and the role of pili and asialo-GM1 may not be significant.
Recent reports using different approaches have demonstrated an increased affinity of Pseudomonas aeruginosa for mucins in cystic fibrosis. Devaraj et al. [14] have shown an increased affinity of Pseudomonas aeruginosa for respiratory mucins in cystic fibrosis. Carnoy et al. [41] have made similar conclusions for C F salivary mucins. These results suggest that respiratory and salivary mucins in CF may have qualitative or quantitative modifications of their carbohydrate chains, increasing their affinity for Pseudomonas aeruginosa.
Using PAGE, blotting on nitrocellulose and radioautography with radio-iodine-labelled mucins, several mucin-binding adhesins have been characterized in the outer membranes of two non-piliated strains of Pseudomonas aeruginosa, 1244-NP and PAK-NP. Four or five proteins are able to bind to the carbohydrate part of human respiratory mucins [42] , but it is not known if they have an increased affinity for CF mucins or if their expression is modified by the hydroionic modifications of the airway surface of CF patients.
Some of these adhesins should have a specificity for oligosaccharides which are recognized by intact Pseudomonas aeruginosa and have the following sequences [43, 44] :
Gal( pl-3) GlcNAc( /l1-3)Gal(/l1-4) . . . Finally, while mucins are generally thought to be protective, it may not be the case in cystic fibrosis, and Vishwanath et al. [45] have shown an increased resistance of Pseudomonas aeruginosa, when incubated in mucins.
In the future, characterization of the main adhesins expressed by Pseudomonas aereuginosa in the lung of CF patients and of their carbohydrate receptors might lead to new concepts in the treatment of the lung infection by Pseudomonas aeruginosa, a bacterium that is more and more resistant to antibiotics.
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